1-10 of 10
Kewal Asosingh
Close
Sort by
Journal Articles

Immunodynamics of Paroxysmal Nocturnal Hemoglobinuria

Carmelo Gurnari, Simona Pagliuca, Adam Wahida, Tariq Kewan, Waled Bahaj, Minako Mori, Bhumika J. Patel, Kewal Asosingh, Valeria Visconte, Jaroslaw P. Maciejewski
Journal: Blood
Blood (2021) 138 (Supplement 1): 1107.
https://doi.org/10.1182/blood-2021-148934
Published: 2021
Journal Articles

Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension

Kewal Asosingh, Samar Farha, Alan Lichtin, Brian Graham, Deepa George, Micheala Aldred, Stanley L. Hazen, James Loyd, Rubin Tuder, Serpil C. Erzurum
Journal: Blood
Blood (2012) 120 (6): 1218–1227.
https://doi.org/10.1182/blood-2012-03-419275
Published: 2012
Journal Articles

Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities

Samar Farha, Kewal Asosingh, Weiling Xu, Jacqueline Sharp, Deepa George, Suzy Comhair, Margaret Park, W. H. Wilson Tang, James E. Loyd, Karl Theil, Raymond Tubbs, Eric Hsi, Alan Lichtin, Serpil C. Erzurum
Journal: Blood
Blood (2011) 117 (13): 3485–3493.
https://doi.org/10.1182/blood-2010-09-306357
Published: 2011
Includes: Supplemental data
Journal Articles

Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model

Eline Menu, Helena Jernberg-Wiklund, Thomas Stromberg, Hendrik De Raeve, Leonard Girnita, Olle Larsson, Magnus Axelson, Kewal Asosingh, Kenneth Nilsson, Ben Van Camp, Karin Vanderkerken
Journal: Blood
Blood (2006) 107 (2): 655–660.
https://doi.org/10.1182/blood-2005-01-0293
Published: 2006
Journal Articles

Inhibiting the IGF-1 Receptor Tyrosine Kinase with Picropodophillin: An In Vitro and In Vivo Study in the 5T33MM Mouse Model.

Karin Vanderkerken, PhD, Eline Menu, Thomas Stromberg, PhD, Hendrik De Raeve, MD, Kewal Asosingh, PhD, Ben Van Camp, MD, PhD, Helena Jernberg-Wiklund, PhD
Journal: Blood
Blood (2004) 104 (11): 640.
https://doi.org/10.1182/blood.V104.11.640.640
Published: 2004
Journal Articles

Role of the Hypoxic Bone Marrow Microenvironment in Multiple Myeloma Tumor Progression.

Kewal Asosingh, PhD, Hendrik De Raeve, MD, Mark de Ridder, MD, Guy A. Storme, MD, PhD, Angelo Willems, Ivan Van Riet, PhD, Benjamin Van Camp, MD, PhD, Karin Vanderkerken, PhD
Journal: Blood
Blood (2004) 104 (11): 2348.
https://doi.org/10.1182/blood.V104.11.2348.2348
Published: 2004
Journal Articles

Angiogenic switch during 5T2MM murine myeloma tumorigenesis: role of CD45 heterogeneity

Kewal Asosingh, Hendrik De Raeve, Eline Menu, Ivan Van Riet, Eric Van Marck, Benjamin Van Camp, Karin Vanderkerken
Journal: Blood
Blood (2004) 103 (8): 3131–3137.
https://doi.org/10.1182/blood-2003-08-2946
Published: 2004
Journal Articles

Multiple myeloma tumor progression in the 5T2MM murine model is a multistage and dynamic process of differentiation, proliferation, invasion, and apoptosis

Kewal Asosingh, Hendrik De Raeve, Ivan Van Riet, Benjamin Van Camp, Karin Vanderkerken
Journal: Blood
Blood (2003) 101 (8): 3136–3141.
https://doi.org/10.1182/blood-2002-10-3000
Published: 2003
Journal Articles

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma

Peter I. Croucher, Claire M. Shipman, Jennifer Lippitt, Mark Perry, Kewal Asosingh, Anja Hijzen, Alex C. Brabbs, Edwin J. R. van Beek, Ingunn Holen, Timothy M. Skerry, Colin R. Dunstan, Graham R. Russell, Ben Van Camp, Karin Vanderkerken
Journal: Blood
Blood (2001) 98 (13): 3534–3540.
https://doi.org/10.1182/blood.V98.13.3534
Published: 2001
Journal Articles

Insulin-Like Growth Factor-1 Acts as a Chemoattractant Factor for 5T2 Multiple Myeloma Cells

Karin Vanderkerken, Kewal Asosingh, Filip Braet, Ivan Van Riet, Ben Van Camp
Journal: Blood
Blood (1999) 93 (1): 235–241.
https://doi.org/10.1182/blood.V93.1.235
Published: 1999